(Q40941953)

25 September 2017

Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice (English)

1 reference

25 September 2017

Operschall E

1

1 reference

25 September 2017

Schuh T

2

1 reference

25 September 2017

Heinzerling L

3

1 reference

25 September 2017

Pavlovic J

4

1 reference

25 September 2017

Moelling K

5

1 reference

25 September 2017

language of work or name

1 reference

1 June 1999

1 reference

Journal of Clinical Virology

25 September 2017

1 reference

25 September 2017

13

1 reference

25 September 2017

1-2

1 reference

25 September 2017

17-27

1 reference

Functional diversity of helper T lymphocytes

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

1 reference

7 January 2021

In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

1 reference

7 January 2021

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

DNA gene vaccination for HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

1 reference

7 January 2021

The granulocyte-macrophage colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Enhancement of humoral immunity by interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Granulocyte-macrophage colony-stimulating factor and the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

La Crosse virus isolations from mosquitoes in Wisconsin, 1964-68.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Immune effector mechanisms required for protection to rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Immunization for Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

Early studies on DNA-based immunizations for measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900008-6

7 January 2021

10.1016/S1386-6532(99)00008-6

Identifiers

DOI

1 reference

25 September 2017

1 reference